Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Phase 3 Study to Evaluate theEfficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following LargeHemispheric Infraction

Project: Research project

Project Details

Description

Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infraction
StatusActive
Effective start/end date7/1/187/1/22

Funding

  • Biogen IDEC

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.